<DOC>
	<DOCNO>NCT00107796</DOCNO>
	<brief_summary>Primary Objectives : The primary objective study determine effectiveness PROVIGIL treatment , compare placebo treatment , child adolescent excessive sleepiness ( ES ) associate narcolepsy , assess : - mean sleep latency Multiple Sleep Latency Test ( MSLT ) ( average 4 nap performed 0900 , 1100 , 1300 , 1500 ) last post-baseline observation ( week 6 early termination ) - Clinical Global Impression Change ( CGI-C ) rating ES , last post-baseline observation ( week 6 early termination ) .</brief_summary>
	<brief_title>Study PROVIGIL ® ( Modafinil ) Treatment Children Adolescents With Excessive Sleepiness Associated With Narcolepsy</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Disorders Excessive Somnolence</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>Diagnosis Main Criteria Inclusion ( Patients include study follow criterion meet ) : Written inform consent/assent obtain A boy girl age 6 16 year , inclusive Meet minimal criterion establish International Classification Sleep Disorders ( ICSD ) manual American Academy Sleep Medicine ( AASM ) narcolepsy ( presumed narcolepsy ) assess follow : *clinical history ; NPSG ( nocturnal polysomnogram ) ( evaluate investigator ) rule sleep disorder ( ie , obstructive sleep apnea/hypopnea syndrome [ OSAHS ] periodic limb movement sleep [ PLMs ] ) ; narcolepsy ( presumed narcolepsy ) identify least 1 follow : MSLT ( evaluate investigator ) ( mean sleep latency [ 4 nap ] &lt; 10 minute ) ; 2 sleep onset REM period ( SOREMP ) ; cataplexy ; sleep paralysis ; hypnogogic hallucination OR *have previous diagnosis narcolepsy basis NPSG and/or MSLT time screen visit Have ES ( MSLT &lt; 10 minute and/or CGI S ≥4 ) direct result inadequate sleep hygiene medical disorder Are good health determine medical psychiatric history , physical examination , ECG , clinical laboratory test Have blood pressure value great 5th percentile less 95th percentile age National High Blood Pressure Education Program guideline blood pressure level boys girl age 6 16 year Girls post menarche sexually active must negative urine pregnancy test prior baseline visit , must use medically acceptable method birth control , must agree continue use method duration study ( 30 day participation study ) . Acceptable method birth control include : barrier method spermicide ; steroidal contraceptive ( eg , oral , transdermal , implanted , inject ) conjunction barrier method ; intrauterine device ( IUD ) ; abstinence . Be able swallow placebo tablet size shape study drug tablet Negative UDS ( urine drug screen ) illicit drug , alcohol ( ethanol ) , stimulant , modafinil screening ; positive stimulant modafinil ( prescribe ES ) screen visit , UDS repeat washout period baseline visit Have parent legal guardian willing participate study Main Criteria Exclusion ( Patients exclude participate study 1 follow criterion meet ) : Have disorder ( ) could consider primary cause ES ( eg , self induce sleep deprivation ) Have past present seizure disorder ( except history single febrile seizure ) , history psychosis , clinically significant head trauma ( eg , brain damage ) past neurosurgery Have history suicide attempt , suicidal risk Have average 5 apneic/hypopneic episode per hour nocturnal sleep assess NPSG baseline visit A clinically significant drug sensitivity stimulant amphetamine , dextroamphetamine , methylphenidate , pemoline ; and/or modafinil component Use prescription ( eg , clonidine , guanfacine ) nonprescription ( counter [ OTC ] ) medication , include dietary supplement psychoactive property ( eg , OTC medication supplement contain ephedrine [ ie , huang ephedra ] , pseudoephedrine , caffeine , phenylpropanolamine ) sedating property ( ie , antihistamine sedative hypnotic ) within 1 week baseline visit ( Note : Medications treatment cataplexy permit patient stable dose least 1 month . ) Use MAO ( monoamine oxidase ) inhibitor SSRIs ( Selective Serotonin Reuptake Inhibitors ) within 2 week baseline visit ( unless use cataplexy ) Received investigational drug ( except modafinil ) within 4 week baseline visit Any disorder could interfere drug absorption , distribution , metabolism , excretion ( include previous gastrointestinal surgery ) Active , clinically significant gastrointestinal , cardiovascular , hepatic , renal , hematologic , neoplastic , endocrine , neurologic , immunodeficiency , pulmonary , major clinically significant disorder/disease Any clinically significant deviation normal range ( ) physical examination ECG finding , clinical laboratory test result ( ie , serum chemistry , hematology , urinalysis ) screen baseline visit ANC ( absolute neutrophil count ) low limit normal screen visit ( Note : If ANC low limit normal baseline visit , medical monitor consult continued eligibility study . ) Seated pulse outside range 60 115 bpm rest 5 minute A history alcohol , narcotic , substance abuse dependence define Diagnostic Statistical Manual American Psychiatric Association , 4th Edition ( DSM IV ) criteria A total daily intake 250 mg caffeine per day ( eg , approximately five 12 ounce caffeinated soda , 2.5 cup coffee tea , 12.5 ounce chocolate per day ) within 1 week baseline visit Pregnant lactating/nursing girl ; girl become pregnant study withdraw A clinically significant illness within 4 week baseline visit ; symptomatic clinically significant illness screen baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Pediatric Narcolepsy</keyword>
	<keyword>Excessive sleepiness</keyword>
</DOC>